Oregon Health & Science University/ Knight Cancer Institute
Portland, Oregon 97239-3098
3 studies enrolling now · 15 studies all time
What they study most
Acute Lymphoblastic Leukemia, Adult B-Cell, Acute Myeloid Leukemia, Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Advanced Breast Cancer, Advanced Prostate Cancer, Allogeneic Hematopoietic Stem Cell Transplantation, Blood Cancer, Breast Cancer, Cancer, Chronic Graft-versus-Host-Disease, Chronic Lymphocytic Leukemia
Studies at this site
- Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer — Recruiting now
- Colonoscopy vs Stool Testing for Older Adults With Colon Polyps — Recruiting now
- Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen — Recruiting now
- PATHFINDER 2: A Multi-Cancer Early Detection Study — Running, not enrolling
- TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer — Running, not enrolling
- Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04) — Running, not enrolling
- The clonoSEQ® Watch Registry — Stopped early
- Study of HPN424 in Patients With Advanced Prostate Cancer — Stopped early
- Biomarker Verification in Pediatric Chronic GvHD: ABLE 2.0 / PTCTC GVH 1901 Study — Status unconfirmed
- The Circulating Cell-free Genome Atlas Study — Status unconfirmed
- Dociparstat Sodium (CX-01) Combined With Standard Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia — Completed
- Electromagnetic Fields Versus Placebo For Child-Pugh A and B Patients With Advanced Hepatocellular Carcinoma — Status unconfirmed
- A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM) — Completed
- 3-arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, a GnRH Antagonist, and Degarelix Alone for Patients With Prostate Cancer With a Rising PSA or a Rising PSA and Nodal Disease Following Definitive Radical Prostatectomy — Completed
- Efficacy of Everolimus Alone or in Combination With Pasireotide LAR in Advanced PNET — Stopped early